For the first time, scientists can take skin cells from people of various ages and transform them into brain cells reflecting the ages of their donors.
Our brain cells change with age: various genes become more or less active, the membrane that holds the nucleus together starts to degenerate, and molecules that in young cells are neatly compartmentalized become scattered and disorganized.
Now scientists have found a way to transform ordinary skin cells into living cultures of aging human neurons—test beds for ways we might reverse these effects of time. In the past, scientists have created neurons in a dish using stem-cell technology, but those efforts produced the equivalent of embryonic neurons. Jerome Mertens of the Salk Institute for Biological Studies and his colleagues took skin cells from donors of different ages and transformed them into neurons that retained the effects of aging. This technique opens up new avenues for studying aging, age-associated diseases, and the possibility that drugs might stave off what was once inevitable.
“These results are obviously going to have an impact,” says John Gearhart, director of the Institute for Regenerative Medicine at the University of Pennsylvania, who was not part of the study. The results will not only advance research into aging, he says, but could aid in the continued quest to create new cells to repair or replace damaged organs.
Gearhart says that the new findings address a major problem in his field. There are several ways to force cells to switch from one type to another, but scientists haven’t been sure how the neurons made from a skin cell differ from the neurons that develop normally in people’s brains.
The earliest method for reprogramming cells set the aging clock back to zero, he says, because the skin cells first had to be turned into a type of stem cell similar to those in early embryos. Mertens and his colleagues tried a newer technique, first developed at Stanford University, in which a series of biochemical tweaks switched skin cells directly into brain cells.
Read more at MIT Technology Review